BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 35777877)

  • 21. Studying the Long-term Impact of COVID-19 in Kids (SLICK). Healthcare use and costs in children and young people following community-acquired SARS-CoV-2 infection: protocol for an observational study using linked primary and secondary routinely collected healthcare data from England, Scotland and Wales.
    Swann OV; Lone NI; Harrison EM; Tomlinson LA; Walker AJ; Seaborne MJ; Pollock L; Farrell J; Hall PS; Seth S; Williams TC; Preston J; Ainsworth JS; Semple FF; Baillie JK; Katikireddi SV; Akbari A; Lyons R; Simpson CR; Semple MG; Goldacre B; Brophy S; Sheikh A; Docherty AB
    BMJ Open; 2022 Nov; 12(11):e063271. PubMed ID: 36356998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective observational study of SARS-CoV-2 infection, transmission and immunity in a cohort of households in Liverpool City Region, UK (COVID-LIV): a study protocol.
    Setiabudi W; Hungerford D; Subramaniam K; Vaselli NM; Shaw VE; Wilton M; Vivancos R; Aston S; Platt G; Moitt T; Jones AP; Gabbay M; Buchan I; Carrol ED; Iturriza-Gomara M; Solomon T; Greenhalf W; Naisbitt DJ; Adams ER; Cunliffe NA; Turtle L; French N;
    BMJ Open; 2021 Mar; 11(3):e048317. PubMed ID: 33737446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.
    Huang L; Li X; Gu X; Zhang H; Ren L; Guo L; Liu M; Wang Y; Cui D; Wang Y; Zhang X; Shang L; Zhong J; Wang X; Wang J; Cao B
    Lancet Respir Med; 2022 Sep; 10(9):863-876. PubMed ID: 35568052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19.
    Taquet M; Dercon Q; Luciano S; Geddes JR; Husain M; Harrison PJ
    PLoS Med; 2021 Sep; 18(9):e1003773. PubMed ID: 34582441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
    Cares-Marambio K; Montenegro-Jiménez Y; Torres-Castro R; Vera-Uribe R; Torralba Y; Alsina-Restoy X; Vasconcello-Castillo L; Vilaró J
    Chron Respir Dis; 2021; 18():14799731211002240. PubMed ID: 33729021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study.
    Adler L; Gazit S; Pinto Y; Perez G; Mizrahi Reuveni M; Yehoshua I; Hoffman R; Azuri J; Patalon T
    Scand J Prim Health Care; 2022 Sep; 40(3):342-349. PubMed ID: 36314555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fatigue and quality-of-life in the year following SARS-Cov2 infection.
    Noujaim PJ; Jolly D; Coutureau C; Kanagaratnam L
    BMC Infect Dis; 2022 Jun; 22(1):541. PubMed ID: 35698068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fatigue and Mental Illness Symptoms in Long COVID: Protocol for a Prospective Cohort Multicenter Observational Study.
    Pires L; Reis C; Mesquita Facão AR; Moniri A; Marreiros A; Drummond M; Berger-Estilita J
    JMIR Res Protoc; 2024 Jan; 13():e51820. PubMed ID: 38241071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Prevalence of COVID-19 Fog and the Impact on Quality of Life After SARS-CoV-2 Infection (QoL-COVID): A Cross Sectional Study.
    Rego de Figueiredo I; Branco Ferrão J; Dias S; Drummond Borges D; Fernandes J; Bernardino V; Gruner H; Panarra A
    Acta Med Port; 2023 Oct; 36(10):631-638. PubMed ID: 36790319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort study.
    Haddad A; Janda A; Renk H; Stich M; Frieh P; Kaier K; Lohrmann F; Nieters A; Willems A; Huzly D; Dulovic A; Schneiderhan-Marra N; Jacobsen EM; Fabricius D; Zernickel M; Stamminger T; Bode SFN; Himpel T; Remppis J; Engel C; Peter A; Ganzenmueller T; Hoffmann GF; Haase B; Kräusslich HG; Müller B; Franz AR; Debatin KM; Tönshoff B; Henneke P; Elling R
    EBioMedicine; 2022 Oct; 84():104245. PubMed ID: 36155957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. One-year persistent symptoms and functional impairment in SARS-CoV-2 positive and negative individuals.
    Nehme M; Braillard O; Chappuis F; Courvoisier DS; Kaiser L; Soccal PM; Reny JL; Assal F; Bondolfi G; Tardin A; Graf C; Zekry D; Stringhini S; Spechbach H; Jacquerioz F; Salamun J; Lador F; Coen M; Agoritsas T; Benzakour L; Favale R; Genevay S; Lauper K; Meyer P; Poku NK; Landis BN; Baggio S; Grira M; Sandoval J; Ehrsam J; Regard S; Genecand C; Kopp G; Guerreiro I; Allali G; Vetter P; Guessous I;
    J Intern Med; 2022 Jul; 292(1):103-115. PubMed ID: 35555926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Follow-up of SARS-CoV-2 positive subgroup from the Asymptomatic novel CORonavirus iNFection study.
    Meyers KJ; Dillman B; Williams C; Jiang J; Clifford N; Miller JL; Jones ME; Goetz IA; Botros FT; Knorr J; Manner DH; Woodward B
    J Med Virol; 2021 May; 93(5):2925-2931. PubMed ID: 33463731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 in first trimester pregnancy: a cohort study.
    la Cour Freiesleben N; Egerup P; Hviid KVR; Severinsen ER; Kolte AM; Westergaard D; Fich Olsen L; Prætorius L; Zedeler A; Christiansen AH; Nielsen JR; Bang D; Berntsen S; Ollé-López J; Ingham A; Bello-Rodríguez J; Storm DM; Ethelberg-Findsen J; Hoffmann ER; Wilken-Jensen C; Jørgensen FS; Westh H; Jørgensen HL; Nielsen HS
    Hum Reprod; 2021 Jan; 36(1):40-47. PubMed ID: 33145598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and determinants of persistent symptoms after treatment for Lyme borreliosis: study protocol for an observational, prospective cohort study (LymeProspect).
    Vrijmoeth HD; Ursinus J; Harms MG; Zomer TP; Gauw SA; Tulen AD; Kremer K; Sprong H; Knoop H; Vermeeren YM; van Kooten B; Joosten LAB; Kullberg BJ; Hovius JWR; van den Wijngaard CC
    BMC Infect Dis; 2019 Apr; 19(1):324. PubMed ID: 30987580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study.
    Fernández-de-Las-Peñas C; Gómez-Mayordomo V; Cuadrado ML; Palacios-Ceña D; Florencio LL; Guerrero AL; García-Azorín D; Hernández-Barrera V; Arendt-Nielsen L
    Cephalalgia; 2021 Nov; 41(13):1332-1341. PubMed ID: 34134526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study.
    Søraas A; Kalleberg KT; Dahl JA; Søraas CL; Myklebust TÅ; Axelsen E; Lind A; Bævre-Jensen R; Jørgensen SB; Istre MS; Kjetland EF; Ursin G
    PLoS One; 2021; 16(8):e0256142. PubMed ID: 34437579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term health consequences among individuals with SARS-CoV-2 infection compared to individuals without infection: results of the population-based cohort study CoMoLo Follow-up.
    Heidemann C; Sarganas G; Du Y; Gaertner B; Poethko-Müller C; Cohrdes C; Schmidt S; Schlaud M; Scheidt-Nave C
    BMC Public Health; 2023 Aug; 23(1):1587. PubMed ID: 37605232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three-Month Symptom Profiles Among Symptomatic Adults With Positive and Negative Severe Acute Respiratory Syndrome Coronavirus 2 Tests: A Prospective Cohort Study From the INSPIRE Group.
    Spatz ES; Gottlieb M; Wisk LE; Anderson J; Chang AM; Gentile NL; Hill MJ; Huebinger RM; Idris AH; Kinsman J; Koo K; Li SX; McDonald S; Plumb ID; Rodriguez RM; Saydah S; Slovis B; Stephens KA; Unger ER; Wang RC; Yu H; Hota B; Elmore JG; Weinstein RA; Venkatesh A
    Clin Infect Dis; 2023 May; 76(9):1559-1566. PubMed ID: 36573005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-acute COVID-19 condition in Saudi Arabia: A national representative study.
    AlRadini FA; Alamri F; Aljahany MS; Almuzaini Y; Alsofayan Y; Khan A; Albogami N; Abdulrahim M; Almogbil A; Alahmari A
    J Infect Public Health; 2022 May; 15(5):526-532. PubMed ID: 35429791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring risk factors for persistent neurocognitive sequelae after hospitalization for COVID-19.
    Ch'en PY; Gold LS; Lu Q; Ye T; Andrews JS; Patel P
    Ann Clin Transl Neurol; 2023 Jul; 10(7):1200-1208. PubMed ID: 37265172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.